← Browse by Condition
Medical Condition

beta lactam resistant bacterial infection

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 4
NCT03671967 Phase 4
Recruiting

PipEracillin Tazobactam Versus mERoPENem for Treatment of Bloodstream Infections Caused by Cephalosporin-resistant Enterobacteriaceae (PETERPEN)

Enrollment
1,084 pts
Location
Canada, Israel
Sponsor
Rambam Health Care Campus
View Trial →